Siegfried Holding AG (0QQO.L)
CHF 978.56
(0.57%)
CHF 978.56
(0.57%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 468.63 Million CHF | -5.99% |
| 2022 | 498.51 Million CHF | 2.29% |
| 2021 | 487.37 Million CHF | 50.85% |
| 2020 | 323.08 Million CHF | -11.61% |
| 2019 | 365.54 Million CHF | 12.09% |
| 2018 | 326.1 Million CHF | 1.32% |
| 2017 | 321.84 Million CHF | -14.28% |
| 2016 | 375.45 Million CHF | 12.15% |
| 2015 | 334.77 Million CHF | 1292.35% |
| 2014 | -28.07 Million CHF | 74.5% |
| 2013 | -110.1 Million CHF | -72.56% |
| 2012 | -63.8 Million CHF | -21.39% |
| 2011 | -52.56 Million CHF | -38.26% |
| 2010 | -38.02 Million CHF | -370.37% |
| 2009 | -8.08 Million CHF | -111.35% |
| 2008 | 71.19 Million CHF | 0.11% |
| 2007 | 71.11 Million CHF | -25.2% |
| 2006 | 95.06 Million CHF | 1347.75% |
| 2005 | -7.61 Million CHF | 39.91% |
| 2004 | -12.68 Million CHF | 12.19% |
| 2003 | -14.44 Million CHF | 54.27% |
| 2002 | -31.57 Million CHF | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 365.54 Million CHF | 0.0% |
| 2023 Q2 | 519.54 Million CHF | 0.0% |
| 2023 Q4 | 468.63 Million CHF | 0.0% |
| 2023 FY | 468.63 Million CHF | -5.99% |
| 2022 Q4 | 498.51 Million CHF | 0.0% |
| 2022 FY | 498.51 Million CHF | 2.29% |
| 2022 Q2 | 485.82 Million CHF | 0.0% |
| 2021 Q2 | 438.38 Million CHF | 0.0% |
| 2021 Q4 | 487.37 Million CHF | 0.0% |
| 2021 FY | 487.37 Million CHF | 50.85% |
| 2020 Q4 | 323.08 Million CHF | 0.0% |
| 2020 FY | 323.08 Million CHF | -11.61% |
| 2020 Q2 | 350.18 Million CHF | 0.0% |
| 2019 Q4 | 365.54 Million CHF | 0.0% |
| 2019 FY | 365.54 Million CHF | 12.09% |
| 2019 Q2 | 318.97 Million CHF | 0.0% |
| 2018 Q4 | 70.12 Million CHF | 0.0% |
| 2018 FY | 326.1 Million CHF | 1.32% |
| 2018 Q2 | -17.07 Million CHF | 0.0% |
| 2017 Q2 | 71.1 Million CHF | 0.0% |
| 2017 Q4 | 65.86 Million CHF | 0.0% |
| 2017 FY | 321.84 Million CHF | -14.28% |
| 2016 Q2 | -13.71 Million CHF | 0.0% |
| 2016 Q4 | 59.69 Million CHF | 0.0% |
| 2016 FY | 375.45 Million CHF | 12.15% |
| 2015 Q2 | -9.52 Million CHF | 0.0% |
| 2015 Q4 | -37.38 Million CHF | 0.0% |
| 2015 FY | 334.77 Million CHF | 1292.35% |
| 2014 Q4 | -28.07 Million CHF | 0.0% |
| 2014 FY | -28.07 Million CHF | 74.5% |
| 2014 Q2 | -58.66 Million CHF | 0.0% |
| 2013 Q2 | -68.36 Million CHF | 0.0% |
| 2013 Q4 | -110.1 Million CHF | 0.0% |
| 2013 FY | -110.1 Million CHF | -72.56% |
| 2012 Q2 | -47.63 Million CHF | 0.0% |
| 2012 FY | -63.8 Million CHF | -21.39% |
| 2012 Q4 | -63.8 Million CHF | 0.0% |
| 2011 Q2 | -55.21 Million CHF | 0.0% |
| 2011 Q4 | -52.56 Million CHF | 0.0% |
| 2011 FY | -52.56 Million CHF | -38.26% |
| 2010 Q2 | -3.95 Million CHF | 0.0% |
| 2010 Q4 | -38.02 Million CHF | 0.0% |
| 2010 FY | -38.02 Million CHF | -370.37% |
| 2009 Q4 | -8.08 Million CHF | 0.0% |
| 2009 FY | -8.08 Million CHF | -111.35% |
| 2008 FY | 71.19 Million CHF | 0.11% |
| 2007 FY | 71.11 Million CHF | -25.2% |
| 2006 FY | 95.06 Million CHF | 1347.75% |
| 2005 FY | -7.61 Million CHF | 39.91% |
| 2004 FY | -12.68 Million CHF | 12.19% |
| 2003 FY | -14.44 Million CHF | 54.27% |
| 2002 FY | -31.57 Million CHF | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Relief Therapeutics Holding AG | -10.24 Million CHF | 4674.3% |
| Tecan Group AG | 183.12 Million CHF | -155.905% |
| Santhera Pharmaceuticals Holding AG | -5.3 Million CHF | 8928.881% |
| Basilea Pharmaceutica AG | 116.11 Million CHF | -303.59% |
| Bachem Holding AG | -157.32 Million CHF | 397.88% |
| Molecular Partners AG | -183.23 Million CHF | 355.755% |